Solitary cutaneous metastasis from an ovarian high‐grade serous carcinoma at the initial presentation: Cytologic diagnosis of a rare manifestation

2021 ◽  
Author(s):  
Amarjot Kaur ◽  
Parikshaa Gupta ◽  
Nalini Gupta ◽  
Bhavana Rai
2018 ◽  
Vol 2018 ◽  
pp. 1-4 ◽  
Author(s):  
Felicity Harl ◽  
Cassandra Niemi ◽  
Lori Mankowski Gettle ◽  
Paul Weisman ◽  
Stephen Rose

A 68-year-old woman presented with a three-week history of confusion and anomic aphasia. Imaging of her head demonstrated a single large left frontal mass. Pathology revealed metastatic adenocarcinoma of Müllerian origin. Subsequent surgery revealed a small primary site in a fallopian tube, high left para-aortic lymphadenopathy, and no disseminated intraperitoneal disease. This case was remarkable in that CNS metastasis was her presenting symptom and was restricted to a solitary brain lesion, and other disease sites were limited to retroperitoneal lymphadenopathy and a small fallopian tube primary.


2013 ◽  
Vol 04 (02) ◽  
pp. 188-190
Author(s):  
Indranil Chakrabarti ◽  
Nilanjana Ghosh ◽  
Amita Giri

ABSTRACTPrimary sarcoma of breast are rare. Diagnosis by aspiration cytology is difficult due to nonspecific cytomorphologic features. An initial presentation with neurological symptoms due to metastasis of breast sarcoma to the brain has not been previously reported. Here, we describe a case of a 60‑year-old female who presented with headache, dizziness and convulsion and was subsequently diagnosed with undifferentiated high grade pleomorphic sarcoma of breast with cerebellar metastasis.


2020 ◽  
Vol 117 (50) ◽  
pp. 31993-32004
Author(s):  
Olga Kim ◽  
Eun Young Park ◽  
Sun Young Kwon ◽  
Sojin Shin ◽  
Robert E. Emerson ◽  
...  

Effective cancer prevention requires the discovery and intervention of a factor critical to cancer development. Here we show that ovarian progesterone is a crucial endogenous factor inducing the development of primary tumors progressing to metastatic ovarian cancer in a mouse model of high-grade serous carcinoma (HGSC), the most common and deadliest ovarian cancer type. Blocking progesterone signaling by the pharmacologic inhibitor mifepristone or by genetic deletion of the progesterone receptor (PR) effectively suppressed HGSC development and its peritoneal metastases. Strikingly, mifepristone treatment profoundly improved mouse survival (∼18 human years). Hence, targeting progesterone/PR signaling could offer an effective chemopreventive strategy, particularly in high-risk populations of women carrying a deleterious mutation in the BRCA gene.


2021 ◽  
Vol 19 (4) ◽  
Author(s):  
Ibrahim Yalcin ◽  
Hanifi Sahin ◽  
Mustafa Erkan Sari ◽  
Asuman Nihan Haberal ◽  
Eda Adeviye Sahin ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document